Posted 5:36 PM 9/15/2014
Sept. 15, 2014 -- Including women ages 70 and over in a national breast cancer screening program does not lead to a large decline in advanced cases, and it may have certain consequences, a Dutch study says.
In the Netherlands, the upper age limit for getting screened was extended from 69 to 75 in 1998. That allowed researchers from the Leiden University Medical Centre to look at the impact on diagnoses of late-stage cancers in this upper age (More)
• Comments (0)
Posted 9:02 PM 8/13/2014
Aug. 13, 2014 -- A new at-home colon cancer test that looks for DNA mutations in stool is more accurate than the stool test currently used, but it won't replace colonoscopies, experts say.
Posted 4:06 PM 7/30/2014
July 30, 2014 -- A biomedical researcher with an unusually aggressive form of breast cancer has taken an extraordinary step to "immortalize" her cancer cells.
Posted 4:52 PM 5/23/2014
May 23, 2014 -- Prostate cancer might be a sexually transmitted disease caused by a common infection, according to a study.
Experts say the research has limitations and is not proof, though.
Posted 8:45 PM 5/14/2013
May 14, 2013 -- Actress and activist Angelina Jolie's recent decision to have a preventive double mastectomy highlights the difficult choices facing women who find out they have a high risk for breast cancer because of their genes.
Posted 9:49 PM 3/6/2013
March 6, 2013 -- Actress Valerie Harper, best known for her role as Rhoda Morgenstern on The Mary Tyler Moore Show and Rhoda in the 1970s, has learned she has leptomeningeal carcinomatosis.
The condition happens when cancer spreads to the brain and spinal cord.
Now 73, Harper told People magazine she received the diagnosis in January.
Posted 9:22 PM 2/28/2013
Posted 5:29 PM 2/15/2013
Feb. 15, 2013 -- IBM's Watson, the supercomputer that grabbed headlines after beating the best contestants on Jeopardy!, now is setting its sights on cancer.
Two years after Watson's victory on the game show, IBM is offering up the pizza-box-sized computer for health care. Its developers have chosen to debut it prominently in cancer care.